Athos Therapeutics, Inc.
AI-based precision therapeutic molecules for autoimmune and inflammatory diseases
New patent ·
- Sector
- Biotech
- Headquarters
- TORRANCE, CA
- Founded
- 2019
- Latest Form D
- $10.3M, May 2026
- Total capital
- $31M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $31M
- 3 Form D · last May 2026
- 5 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 3
- 26 pending · first 2022
- Rank in peer group#339 of 1449
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 3rd filing$10.3M
- Private capital raisedForm D · SEC · 2nd filing$7.6M
- Private capital raisedForm D · SEC · 1st filing$13.2M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 1449 peers
Line = medianBiotech · Molecule
- Granted patents#339 · top 23%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Dimitrios IliopoulosResearcherExecutive Officer, DirectorLinked by 1 patent
- Allan J. PantuckExecutive Officer, DirectorNamed in SEC Form D filings
- Anthony J. ZingaleDirectorNamed in SEC Form D filings
- Carl J. McKinzieDirectorNamed in SEC Form D filings
- Joel J. CohenDirectorNamed in SEC Form D filings
- Laurence J. SteinDirectorNamed in SEC Form D filings
What it has protected
USPTO · 3 granted of 29- New patentPharmaceutical Compounds And Methods Of Making And Using The SameUSPTOUS 12,747,208
- PendingData Integration And Quality Control SystemUSPTOApplication 19294043
- GrantedData Integration And Quality Control SystemUSPTOUS 12,387,013
Show all 29 patent records
- Pharmaceutical Compounds And Methods Of Making And Using The SameSep 29, 2026 · US 12,747,208Granted
- Data Integration And Quality Control SystemJul 2, 2026 · Application 19294043Pending
- Data Integration And Quality Control SystemAug 12, 2025 · US 12,387,013Granted
- Ex Vivo Colonic Biopsy Platform To Evaluate Multi-omic Signatures For Screening Candidate TherapeuticsJul 31, 2025 · Application 18040422Pending
- Triazine Compounds And Methods Of Making And Using The SameJun 12, 2025 · Application 18262712Pending
- VANIN-1 InhibitorsFeb 27, 2025 · Application 18892257Pending
- Pharmaceutical Compounds And Methods Of Making And Using The SameFeb 6, 2025 · Application 18262676Pending
- Small Molecules For The Treatment Of Kinase-related DiseasesJun 20, 2024 · Application 18551281Pending
- Small Molecules For The Treatment Of Autoimmune Diseases And CancerMay 25, 2023 · Application 17961437Pending
- Small Molecules For The Treatment Of Autoimmune Diseases And CancerNov 1, 2022 · US 11,485,728Granted
- Small Molecules For The Treatment Of Autoimmune Diseases And CancerApplication PCTUS2021044692Pending
- Small Molecules For The Treatment Of Kinase-related DiseasesApplication 63165604Pending
- Triazine Compounds And Methods Of Making And Using The SameApplication 63141316Pending
- Pyrrole Compounds And Methods Of Making And Using The SameApplication 63141326Pending
- Ex Vivo Colonic Biopsy Platform To Evaluate Multi-omic Signatures For Screening Candidate TherapeuticsApplication 63062954Pending
- Small Molecules For The Treatment Of Autoimmune Diseases And CancerApplication 63062670Pending
- Small Molecules For The Treatment Of Autoimmune Diseases And CancerApplication 19530949Pending
- Small Molecules For The Treatment Of Autoimmune DisordersApplication 19496858Pending
- VANIN-1 InhibitorsApplication 19167333Pending
- Pharmaceutical Compounds And Methods Of Making And Using The SameApplication PCTUS2022070319Pending
- Data Integration And Quality Control SystemApplication 63740228Pending
- Small Molecules For The Treatment Of Autoimmune DisordersApplication PCTUS2024035260Pending
- VANIN-1 InhibitorsApplication PCTUS2024020364Pending
- Small Molecules For The Treatment Of Autoimmune DisordersApplication 63510291Pending
- VANIN-1 InhibitorsApplication 63491415Pending
- Small Molecules For The Treatment Of Kinase-related DiseasesApplication PCTUS2022071268Pending
- Omics Data Integration And Quality Control SystemApplication PCTUS2025057992Pending
- Triazine Compounds And Methods Of Making And Using The SameApplication PCTUS2022070321Pending
- Ex Vivo Gastrointestinal Biopsy Platform To Evaluate Multi-omic Signatures For Screening Candidate TherapeuticsApplication PCTUS2021044714Pending
Related companies, and why
- Pulmatrix Operating Company, Inc.Similar federal contract value in Biotech · null in contracts
- Tarsa Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
- Pasithea Therapeutics Corp.Similar federal contract value in Biotech · null in contracts
- STEM CELL THERAPEUTICS CORPSimilar federal contract value in Biotech · null in contracts
- Guardian Therapeutics, LLCSimilar federal contract value in Biotech · null in contracts
- Nexo TherapeuticsSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .